Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic UltraSound in Potentially Resectable PAncreatic Malignancy - Does it Bear the Weight of the Rapidly Evolving Technology of Computer Tomography?

NCT02115022 is registered in ClinicalTrials.gov with Clinical Hospital Colentina as lead sponsor.

NCT NCT02115022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02115022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic UltraSound in Potentially Resectable PAncreatic Malignancy - Does it Bear the Weight of the Rapidly Evolving Technology of Computer Tomography?
Lead sponsor
Clinical Hospital Colentina
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
February 28, 2018
Enrollment
45 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

resectable pancreatic cancer